跳至主要内容
临床试验/NCT03704155
NCT03704155已完成不适用

Effect of Botulinum Toxin Type A Associated With Physical Therapy on the Functional Capacity of Children With Spastic Cerebral Palsy: A Randomized Controlled Clinical Trial

University of Nove de Julho0 个研究点目标入组 24 人开始时间: 2017年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
24
主要终点
Severity of muscle hypertonia

研究概览

简要总结

Purpose: The aim of this study was investigate the effects of botulinum toxin type A (BoNT-A) associated with physical therapy on the functional capacity of children with spastic cerebral palsy (CP). Material and methods: Twenty-four children with spastic CP were concealed and randomly assigned to the Experimental Group (EG) consisting of 12 patients treated with BoNT-A and physical therapy and Control with 12 patients treated only with physical therapy. All participants were assessed through motor and functional scales (GMFM-88, Ashworth, Berg Balance Scale, TUG test and Pediatric Evaluation of Disability Inventory) at three different times: before and after 30 days of treatment as well as 3 months after the end of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Evaluator 1: triage, random draw of treatments to be performed; Evaluator 2: BoNT-A application; Evaluator 3: assessment data collection; Evaluator 4: physical therapy treatment. Evaluator 3 was blinded in relation to the groups.

入排标准

年龄范围
5 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of spastic Cerebral Palsy
  • Clinical diagnosis of Dynamic equine feet

排除标准

  • Use of phenol in the last 12 months
  • Neurological blocks in the last 6 months
  • Clinical diagnosis of structured orthopedic deformities with surgical indications

研究组 & 干预措施

Experimental group (EG)

Experimental

The EG was treated with Botulinum toxin type A and physiotherapy (stretching, balancing training, functional walking training).

干预措施: Botulinum toxin type A (Drug)

Experimental group (EG)

Experimental

The EG was treated with Botulinum toxin type A and physiotherapy (stretching, balancing training, functional walking training).

干预措施: Physical Therapy (Other)

Control group (CG)

Active Comparator

GC was treated with physiotherapy (stretching, balancing training, functional walking training).

干预措施: Physical Therapy (Other)

结局指标

主要结局

Severity of muscle hypertonia

时间窗: 3 months

The classification of hypertonia was performed by Modified Ashworth Scale

Functional balance

时间窗: 3 months

Functional balance was assessed using the Berg Balance Scale (BBS).

次要结局

  • Functional mobility(3 months)
  • Functional performance(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fabiano Politti

Principal Investigator

University of Nove de Julho

相似试验

尚未招募
不适用
Botulinum toxin type A injections in stiff knee gait.In the Netherlands live about 18.000 Cerebro Vascular Accident (CVA)-patients which discover problems with walking caused by insufficient footclearance. Causes of problems with the footclearance during the swing phase of gait are a combination of diminished dorsal flexion of the ankle, knee flexion and hip flexion. A diminished knee flexion during swing is defined a stiff knee gait. A stiff knee gait is often caused by an overactivity of the m. rectus femoris. Keywords: stroke, stiff knee gait
NL-OMON29171Roessingh Research and DevelopmentRoessinghsbleekweg 337577 AH Enschede26
已完成
4 期
Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral PalsyCerebral Palsy Spastic Diplegia
NCT06583343Gaziosmanpasa Research and Education Hospital40
终止
不适用
The Effect of Botulinum Toxin A Injections on Ankle Dorsiflexion Following Internal Fixation of Tibial Pilon FracturesEquinus Contracture
NCT02051933Wake Forest University Health Sciences10
招募中
3 期
Evaluation the effect of Botulinium toxin injection on improving symptoms in patients with diabetic neuropathy
IRCT20240116060710N1Shahid Beheshti University of Medical Sciences30
已完成
不适用
comparison of the effect of botulinium toxin A injection with placebo in reducing the pain of patients with myofacial paitemporomandibular disorder.Temporomandibular joint disorders
IRCT2016051527894N2Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences34